Buyback yield (TTM)
N/A
Shareholder yield (TTM)
N/A
5Y share count change
351.4%
Buyback spend (TTM)
N/A
Cumulative buybacks
$416.00K
Key takeaways
- Diluted share count is up 351.4% over the last ~5 fiscal years — equity issuance and stock-based compensation are outpacing repurchases.
Dividend & buyback yield over time for Equillium (EQ)
Stacked annual yields — buyback yield (TTM cash repurchases ÷ market cap) plus dividend yield from the same fiscal-year-end key-metrics period — show how total cash return per dollar of equity has evolved.
Diluted vs basic shares (annual) for Equillium (EQ)
Diluted weighted-average shares are the EPS denominator — a falling count means buybacks are outpacing SBC dilution.
Year-over-year change in diluted shares for Equillium (EQ)
Green is fewer shares vs the prior fiscal year (net repurchase); red is growth (dilution). The earliest year shown has no prior year to compare.
Cash buyback spend over time for Equillium (EQ)
Latest: $0.00
Overview
As of the 2025 fiscal year, Equillium (EQ) reported buyback spend of $0.00.
Equillium buyback spend plunged from $260.00K in 2023 to $0.00 in 2025, a 100.0% drawdown.
The record annual buyback spend stands at $260.00K, reached in 2023; the historical low of $0.00 was recorded in 2017.
Equillium Buyback Spend 2025: $0.00
Equillium buyback spend in 2025 was $0.00.
Equillium Buyback Spend 2024: $0.00
In 2024, Equillium reported buyback spend of $0.00, plunged 100.0% below 2023.
Equillium Buyback Spend 2023: $260.00K
Equillium buyback spend in 2023 was $260.00K.
Equillium Buyback Spend 2022: $0.00
Equillium buyback spend in 2022 was $0.00.
Equillium Buyback Spend 2021: $0.00
Equillium buyback spend in 2021 was $0.00.
See more financial history for Equillium (EQ).
Buyback, SBC & dilution history
Buyback spend, SBC, net dilution effect, and share count.
| 2025 | $0.00 | $2.32M | −$2.32M | — | 0.09B | +159.9% | |
| 2024 | $0.00 | $3.75M | −$3.75M | — | 0.04B | +1.8% | |
| 2023 | $260.00K | $4.00M | −$3.74M | 1.02% | 0.03B | +3.0% | |
| 2022 | $0.00 | $4.84M | −$4.84M | — | 0.03B | +17.1% | |
| 2021 | $0.00 | $4.41M | −$4.41M | — | 0.03B | +41.5% | |
| 2020 | $0.00 | $3.82M | −$3.82M | — | 0.02B | +17.1% | |
| 2019 | $156.00K | $2.25M | −$2.10M | 0.27% | 0.02B | +42.6% | |
| 2018 | $0.00 | $441.91K | −$441.91K | — | 0.01B | +4.4% | |
| 2017 | $0.00 | $0.00 | $0.00 | — | 0.01B | — |
- 2025$0.00
- 2024$0.00
- 2023$260.00K
- 2022$0.00
- 2021$0.00
- 2020$0.00
- 2019$156.00K
- 2018$0.00
- 2017$0.00
Buybacks vs stock-based compensation for Equillium (EQ)
Annual cash repurchases set against stock-based compensation. Coverage above 1× means buybacks fully offset the equity dilution from SBC. TTM coverage: 0.00×.
Buybacks vs dividends (share of cash returned) for Equillium (EQ)
How Equillium splits cash returned to shareholders between dividends and buybacks.
Sector peers by buyback spend
Companies in the same sector as Equillium, ranked by their latest buyback spend.
| $5.95B | |
| $5.54B | |
| $5.08B | |
| $4.11B | |
| $980.00M | |
| $719.66M | |
| $216.35M | |
| $0.00 |
- $5.95B
- $5.54B
- $5.08B
- $4.11B
- $980.00M
- $719.66M
- $216.35M
- $0.00
Buyback capacity (TTM)
Free cash flow minus dividends paid versus actual TTM repurchases — the headroom bar shows how much of post-dividend FCF is still being deployed elsewhere.
Headroom $0.00 (TTM FCF − TTM dividends, clamped at zero).
Frequently asked questions
Data & methodology
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation